SMO Clinplus Co Ltd - Class A

SZSE:301257 (China)   Class A
Â¥ 29.57 (+0.85%) Jun 7
17.49
P/B:
2.12
Market Cap:
Â¥ 2.35B ($ 324.38M)
Enterprise V:
Â¥ 1.46B ($ 198.08M)
Volume:
1.25M
Avg Vol (2M):
1.52M
Volume:
1.25M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for SMO Clinplus Co Ltd ( SZSE:301257 ) from 2022 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. SMO Clinplus stock (SZSE:301257) PE ratio as of Jun 07 2024 is 17.49. More Details

SMO Clinplus Co Ltd (SZSE:301257) PE Ratio (TTM) Chart

To

SMO Clinplus Co Ltd (SZSE:301257) PE Ratio (TTM) Historical Data

Total 508
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
SMO Clinplus PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-07 17.6 2024-04-05 22.6
2024-06-07 17.6 2024-04-03 22.6
2024-06-06 17.4 2024-04-02 23.4
2024-06-05 18.3 2024-04-01 23.6
2024-06-04 18.8 2024-03-29 22.5
2024-06-03 18.9 2024-03-28 22.5
2024-05-31 19.5 2024-03-27 21.7
2024-05-30 19.3 2024-03-26 22.2
2024-05-29 19.2 2024-03-25 22.8
2024-05-28 19.1 2024-03-22 23.3
2024-05-27 19.4 2024-03-21 24.2
2024-05-24 19.3 2024-03-20 24.5
2024-05-23 19.7 2024-03-19 23.7
2024-05-22 20.4 2024-03-18 24.5
2024-05-21 20.3 2024-03-15 23.6
2024-05-20 20.5 2024-03-14 24.3
2024-05-17 20.4 2024-03-13 23.3
2024-05-16 20.4 2024-03-12 22.8
2024-05-15 20.2 2024-03-11 22.1
2024-05-14 20.7 2024-03-08 21.3
2024-05-13 20.5 2024-03-07 20.9
2024-05-10 21.4 2024-03-06 21.7
2024-05-09 21.6 2024-03-05 21.4
2024-05-08 21.2 2024-03-04 23.1
2024-05-07 21.4 2024-03-01 22.0
2024-05-06 21.4 2024-02-29 22.1
2024-05-03 20.6 2024-02-28 21.4
2024-05-02 20.6 2024-02-27 22.8
2024-04-30 20.6 2024-02-26 22.2
2024-04-29 20.9 2024-02-23 22.0
2024-04-26 21.0 2024-02-22 21.2
2024-04-25 20.4 2024-02-21 20.9
2024-04-24 19.8 2024-02-20 21.0
2024-04-23 19.6 2024-02-19 20.5
2024-04-22 19.8 2024-02-16 20.5
2024-04-19 20.2 2024-02-09 20.5
2024-04-18 20.2 2024-02-08 20.5
2024-04-17 20.4 2024-02-07 17.5
2024-04-16 19.4 2024-02-06 17.4
2024-04-15 21.0 2024-02-05 16.6
2024-04-12 21.8 2024-02-02 18.3
2024-04-11 22.0 2024-02-01 19.4
2024-04-10 22.8 2024-01-31 19.5
2024-04-09 23.7 2024-01-30 20.9
2024-04-08 21.9 2024-01-29 21.9

SMO Clinplus Co Ltd (SZSE:301257) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.